Dynamics of angiogenesis in ischemic areas of the infarcted heart

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Cardiac Pathophysiology

Background:

• Hypoxia during myocardial infarction (MI) causes cardiomyocyte apoptosis.
• Angiogenesis is a potential therapeutic strategy to mitigate MI damage.
• The precise timing and mechanism of cardiac angiogenesis post-MI remain unclear.

Purpose of the Study:

• To investigate the mechanism and timing of new blood vessel formation in the heart after MI.
• To identify therapeutic targets for angiogenic therapy in myocardial infarction.

Main Methods:

• Utilized a mouse model of myocardial infarction.
• Investigated cardiomyocyte apoptosis and new vessel formation using histological and molecular analyses.
• Examined the role of vascular endothelial growth factor (VEGF) signaling.

Main Results:

• Identified a novel circulatory system where new vessels grow from the left ventricle endocardium 3-14 days post-MI.
• This endocardial angiogenesis, activated by VEGF signaling, perfuses hypoxic areas and salvages cardiomyocytes.
• Cardiomyocytes in the border zone underwent apoptosis within 12 hours, indicating a transient therapeutic window.

Conclusions:

• The non-perfused endocardial area is a site of active angiogenesis and a promising therapeutic target for myocardial infarction.
• Targeting endocardial angiogenesis offers a strategy to improve cardiomyocyte survival and reduce adverse ventricular remodeling post-MI.